Rare de novo mutations in genes associated with inherited Mendelian disorders are potential contributors to sporadic disease. DYT1 dystonia is an autosomal dominant, early-onset, generalized dystonia associated with an inframe, trinucleotide deletion (n. delGAG, p. ΔE 302/303) in the Tor1a gene. Here we examine the significance of a rare missense variant in the Tor1a gene (c. 613T N A, p. F205I), previously identified in a patient with sporadic late-onset focal dystonia, by modeling it in mice. Homozygous F205I mice have motor impairment, reduced steady-state levels of TorsinA, altered corticostriatal synaptic plasticity, and prominent brain imaging abnormalities in areas associated with motor function. Thus, the F205I variant causes abnormalities in domains affected in people and/or mouse models with the DYT1 Tor1a mutation (ΔE). Our findings establish the pathological significance of the F205I Tor1a variant and provide a model with both etiological and phenotypic relevance to further investigate dystonia mechanisms.
Introduction
Dystonia is a neurological movement disorder characterized by involuntary twisting movements and abnormal postures. Environmental, genetic and sporadic cases together make dystonia among the top 3 conditions evaluated in Movement Disorder specialty clinics (Nutt et al., 1988) . Of the early-onset isolated dystonias, DYT1 dystonia is among the most common (Balint and Bhatia, 2015; Ozelius L, 2014) . DYT1 dystonia is an autosomal dominant disease with incomplete penetrance that is due to an in-frame trinucleotide deletion in the Tor1a gene resulting in the loss of a glutamic acid residue (ΔE) from the TorsinA protein (Bressman et al., 1989; Risch et al., 1990) . It is an early-onset generalized dystonia, presenting in childhood and involving much of the body. In DYT1 dystonia, human neuroimaging abnormalities have been documented in several parts of the brain involved in motor function, including the cerebellum (Carbon et al., 2004b; Eidelberg et al., 1998) , sensorimotor cortex (Carbon et al., 2004a; Carbon et al., 2008) and basal ganglia (Carbon et al., 2004b; Ghilardi et al., 2003; Trost et al., 2002) . Mouse DYT1 dystonia models share some of these neuroimaging motor circuit abnormalities (Grundmann et al., 2007; Ulug et al., 2011; Vo et al., 2014) and also have impaired synaptic plasticity in a brain region associated with dystonia expression, the striatum of the basal ganglia (Martella et al., 2014; Martella et al., 2009) . Interestingly, phenotypic validity has not been as readily recapitulated in mouse heterozygous ΔE knock-in models (Dang et al., 2005; Goodchild et al., 2005; Tanabe et al., 2012) . Nonetheless, conditional genetic models that eliminate all wild-type protein (Liang et al., 2014; Pappas et al., 2015) or heavily over-express the protein (Grundmann et al., 2007) demonstrate proof-of-principle that TorsinA perturbations can impact motor behavior.
Rare variants in the Tor1a gene, as well as other genes associated with dystonia, have been reported in cases of sporadic dystonias (Calakos et al., 2010; Dobričić et al., 2015; Dufke et al., 2014; Groen et al., 2015; Groen et al., 2014; Hettich et al., 2014; Kock et al., 2006; Kumar et al., 2014; Lohmann et al., 2012; Nibbeling et al., 2015; Saunders-Pullman et al., 2014; Vemula et al., 2014; Vulinovic et al., 2014; Zech et al., 2014; Ziegan et al., 2014) , suggesting this as one potential genetic contribution to disease. However, obtaining formal genetic support, as in association studies, is fundamentally challenged when rare genetic events occur in rare disorders. In this study, we tested the pathophysiological significance of a rare Tor1a variant by modeling it in mice. This missense variant, which results in the substitution of Neurobiology of Disease 93 (2016) 137-145 
